Free Trial

Edwards Lifesciences (EW) Earnings Date, Estimates & Call Transcripts

Edwards Lifesciences logo
$73.25 -1.46 (-1.95%)
Closing price 03:59 PM Eastern
Extended Trading
$73.30 +0.05 (+0.07%)
As of 06:00 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Edwards Lifesciences Latest Earnings Summary

Upcoming Q1
Earnings Date
Apr. 24After Market ClosesEstimated
Actual EPS
(Feb. 11)
$0.59 Beat By $0.04
Consensus EPS
(Feb. 11)
$0.55

Edwards Lifesciences released Q4 2024 earnings on February 11, 2025, reporting an EPS of $0.59, which beat the consensus estimate of $0.55 by $0.04. With a trailing EPS of $6.97 and a P/E Ratio of 10.51, Edwards Lifesciences' earnings are expected to grow 12.24% next year, from $2.45 to $2.75 per share.

EW Upcoming Earnings

Edwards Lifesciences' next earnings date is estimated for Thursday, April 24, 2025, based off prior year's reporting schedules.

Get Edwards Lifesciences Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Edwards Lifesciences and other key companies, straight to your inbox.

Sign Up
Skip Charts & View Estimated and Actual Earnings Data

EW Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

EW Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Edwards Lifesciences Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany Guidance
Q1 20253$0.57$0.58$0.580.580 - 0.640
Q2 20253$0.60$0.62$0.61 
Q3 20253$0.60$0.61$0.60 
Q4 20253$0.63$0.64$0.63 
FY 202512$2.40$2.45$2.43 
Q1 20262$0.65$0.67$0.66 
Q2 20262$0.67$0.68$0.68 
Q3 20262$0.67$0.71$0.69 
Q4 20262$0.72$0.72$0.72 
FY 20268$2.71$2.78 $2.75

Edwards Lifesciences Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
4/24/2025
(Estimated)
-------
2/11/2025Q4 2024$0.55$0.59+$0.04$0.65$1.36B-
10/24/2024Q3 2024$0.67$0.67--$3.79$1.57B$1.35B
7/24/2024Q2 2024$0.69$0.70+$0.01$0.79$1.65B$1.63B
4/25/2024Q1 2024$0.64$0.66+$0.02$0.74$1.58B$1.60B
2/6/2024Q4 2023$0.64$0.64-$0.67$1.50B$1.53B
10/25/2023Q3 2023$0.59$0.59-$0.55$1.48B$1.48B
7/26/2023Q2 2023$0.65$0.66+$0.01$0.82$1.51B$1.53B
4/26/2023Q1 2023$0.61$0.62+$0.01$0.68$1.39B$1.46B

Edwards Lifesciences Earnings - Frequently Asked Questions

Edwards Lifesciences has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, April 24th, 2025 based off last year's report dates. Learn more on EW's earnings history.

Edwards Lifesciences issued an update on its first quarter 2025 earnings guidance on Tuesday, February, 11th. The company provided earnings per share guidance of 0.580-0.640 for the period, compared to the consensus earnings per share estimate of 0.590. The company issued revenue guidance of $1.4 billion-$1.4 billion, compared to the consensus revenue estimate of $1.4 billion.

In the previous quarter, Edwards Lifesciences (NYSE:EW) reported $0.59 earnings per share (EPS) to beat the analysts' consensus estimate of $0.55 by $0.04. Learn more on analysts' earnings estimate vs. EW's actual earnings.

The conference call for Edwards Lifesciences's latest earnings report can be listened to online.
Listen to Conference Call

The conference call transcript for Edwards Lifesciences's latest earnings report can be read online.
Read Transcript

Edwards Lifesciences (NYSE:EW) has a recorded annual revenue of $5.44 billion.

Edwards Lifesciences (NYSE:EW) has a recorded net income of $4.17 billion. EW has generated $6.97 earnings per share over the last four quarters.

Edwards Lifesciences (NYSE:EW) has a trailing price-to-earnings ratio of 10.51 and a forward price-to-earnings ratio of 29.90. The price/earnings-to-growth ratio is 4.82.

Edwards Lifesciences's earnings are expected to grow from $2.45 per share to $2.75 per share in the next year, which is a 12.24% increase.

More Earnings Resources from MarketBeat



This page (NYSE:EW) was last updated on 2/21/2025 by MarketBeat.com Staff
From Our Partners